PARCC and OrganX Forge a Partnership to Accelerate Organ Health Advances

PARCC and OrganX Forge a Partnership to Accelerate Organ Health Advances

We are thrilled to announce a new collaboration between the PARCC and OrganX, a nonprofit organization dedicated to accelerating advances in organ technologies and patient access to organ health.

This partnership unites the innovative research capabilities of PARCC’s interdisciplinary teams with OrganX’s mission-driven approach. Specifically, this collaboration will involve the expertise of the PARCC team led by Dr. Alexandre Loupy, which focuses on translating immunological and gene expression discoveries into clinical applications for organ transplantation.

By working together, we aim to bridge the gap between basic scientific research and applied biomedical solutions. This alliance will enable us to:

• Accelerate the development of new knowledge and theranostic approaches for cardiovascular diseases.
• Translate groundbreaking discoveries in immunity and gene expression directly into the clinical field of organ transplantation.
• Identify relevant and non-invasive biomarkers and rejection gene expression signatures to improve patient outcomes.

This partnership represents a significant step forward in our shared commitment to revolutionize organ health and transplantation. We look forward to the impactful discoveries and advancements that will result from this collaboration.